COMMUNIQUÉS West-GlobeNewswire

Assemblée Générale Mixte du 22 mai 2025 - Modalités de mise à disposition des documents préparatoires
30/04/2025
Daix (France), New York City (New York, Etats-Unis), le 30 avril 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique [...]
DBV Technologies Reports First Quarter 2025 Financial Results
30/04/2025
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage [...]
DBV Technologies publie ses résultats financiers du 1er trimestre 2025
30/04/2025
Châtillon, France, le 30 avril (22 :00 CEST) 2025 DBV Technologies publie ses résultats financiers du 1er trimestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : [...]
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
30/04/2025
Company to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET IRVINE, California – April 30, 2025 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, [...]
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
30/04/2025
WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of intent for a facility [...]
FSR Celebrates Congressional Recognition of April as Sarcoidosis Awareness Month
30/04/2025
Announcement coincides with Foundation’s 25th anniversary and recent FMLA clarification supporting clinical trial access CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) today [...]
FORM 8.1(a) & (b) - Mural Oncology plc
30/04/2025
Ap9 FORM 8.1(a) & (b) (Opening Position Disclosure) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE [...]
Best Probiotic for Women Weight Loss and Vaginal Health - Top Women's Probiotic Supplement for Constipation and Gut Health - YourBiology
30/04/2025
Glasgow, April 30, 2025 (GLOBE NEWSWIRE) -- Are you searching for the best probiotics for women's weight loss and vaginal health? Did you know your gut and vaginal health are closely connected? This "gut-vagina axis" [...]
Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
30/04/2025
PALO ALTO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Spotlight on Happy Go Leafy's Maeng Da Kratom: A Trusted Botanical for Experienced Kratom Enthusiasts
30/04/2025
Happy Go Leafy’s Maeng Da Kratom offers premium quality with energizing, calming, and pain-relieving effects. Perfect for both experienced and new users. Miami, Florida, April 30, 2025 (GLOBE NEWSWIRE) -- Happy Go Leafy [...]
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
30/04/2025
CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
Press Release: Annual General Meeting of April 30, 2025
30/04/2025
Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024 Distribution of a cash dividend of €3.92 per share, with payment as of May 14, 2025 Board composition: renewal of [...]
Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2025
30/04/2025
Assemblée Générale Annuelle du 30 avril 2025 Approbation des comptes sociaux et des comptes consolidés de l’exercice 2024 Distribution d’un dividende en numéraire de 3,92 euros par action, dont la mise en paiement [...]
Interim Report Q1 2025: Growth challenged by market uncertainty – proactive cost mitigation initiated to support long-term margins
30/04/2025
Highlights The Hearing division delivered -1% organic revenue growth driven by a strong initial uptake of ReSound Vivia, but off-set by a challenged U.S. market as well as some slowdown of existing products in [...]
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
30/04/2025
Information relating to the holding of the Combined Shareholders’ Meeting of 21 May 2025 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting PARIS, FRANCE, 30 April 2025 - [...]
EssilorLuxottica: EssilorLuxottica 2025 Annual Shareholders’ Meeting
30/04/2025
EssilorLuxottica 2025 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adopted Dividend of Euro 3.95 per share, with option for payment in shares Paris, France (30 April 2025 – 6:00 pm [...]
EssilorLuxottica: Assemblée générale 2025 d’EssilorLuxottica
30/04/2025
Assemblée générale 2025 d’EssilorLuxottica Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 3,95 € par action, avec possibilité de choisir un versement en actions Paris, France (30 [...]
IPSEN S.A - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale 2025
30/04/2025
Information réglementée Destiné uniquement aux médias internationaux et à la communauté d’investisseurs Informations concernant la tenue de l’Assemblée Générale Mixte du 21 mai 2025 d’Ipsen S.A. Modalités de mise à [...]
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024
30/04/2025
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024 NANTES, France, 30 avril 2025, 18 heures - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), une société de [...]

Pages